Presenting author

Giuseppe Plazzi

1 presentation

• T60. Safety and efficacy results from the phase 2 VIBRANCE-1 study of the orexin 2 receptor agonist alixorexton in patients with narcolepsy type 1

  2026 ASCP Annual Meeting